Roswell Park forms for-profit biotechnology company

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

ROSWELL PARK CANCER INSTITUTE announced the formation of Global Biotechnology & Cancer Therapeutics, a for-profit company that will support biotech and life-sciences startups. “GBCT will allow outside biotechnology companies to partner with a scientifically respected entity that will provide infrastructure for drug development and investment — everything from clinical trials to anticancer agents and vaccines,...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The landscape of cancer care in America faces critical challenges: geographic disparities in access, socioeconomic barriers to advanced treatments and the increasing complexity of precision medicine that outpaces individual providers’ ability to stay current. At City of Hope, we are addressing these systemic issues through a bold expansion that brings world-class cancer care and research closer to where patients live.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login